UK policy statements on testosterone deficiency-Reference-Cited by-同舟云学术

UK policy statements on testosterone deficiency

Published:2017-03 Issue:3-4 Volume:71 Page:e12901
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Hackett Geoffrey¹²,Kirby Michael³⁴^ORCID,Edwards David⁵⁶,Jones T. Hugh⁷⁸⁹,Rees Jonathan¹⁰¹¹,Muneer Asif⁶¹²

Affiliation:

1. Good Hope Hospital; Birmingham UK

2. University of Bedfordshire; Luton UK

3. Faculty of Health & Human Sciences; University of Hertfordshire; Hatfield UK

4. The Prostate Centre; London UK

5. White House Surgery; Chipping Norton UK

6. British Society for Sexual Medicine (BSSM); Staffordshire UK

7. Barnsley Hospital; Barnsley UK

8. University of Sheffield Medical School; Sheffield UK

9. Royal Hallamshire Hospital; Sheffield UK

10. Backwell & Nailsea Medical Group; Bristol UK

11. Primary Care Urology Society; London UK

12. Department of Urology and NIHR Biomedical Research Centre University College London Hospitals; London UK

Funder

Bayer

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijcp.12901/fullpdf

Reference58 articles.

1. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of testosterone and cardiovascular risk;Goodman;Endocr Pract,2015

2. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels;Vigen;JAMA,2013

3. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men;Finkle;PLoS ONE,2014

4. FDA testosterone products: drug safety communication-FDA investigating risk of cardiovascular events http://www.fda.gov/safety/medwatch/safetyinfomation/safetyalertsforhumanmedicalproducts/ucm384225.htm

5. European Medicines Agency No consistent evidence of heart attacks with testosterone medications http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Testosterone_31/Position_provided_by_CMDh/WC500177617.pdf

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plin4 exacerbates cadmium-decreased testosterone level via inducing ferroptosis in testicular Leydig cells;Redox Biology;2024-10

2. Diagnosis and treatment of hypogonadism in men seeking to preserve fertility – what are the options?;International Journal of Impotence Research;2024-04-30

3. Barriers to diagnosis and accessing effective treatment and support for testosterone deficiency;Journal of Men's Health;2024

4. Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India;International Journal of Endocrinology;2023-02-22

5. The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice;The World Journal of Men's Health;2023